Genotoxic stress-induced nuclear localization of oncoprotein YB-1 in the absence of proteolytic processing

被引:49
作者
Cohen, S. B. [1 ,2 ]
Ma, W. [1 ]
Valova, V. A. [3 ]
Algie, M. [4 ]
Harfoot, R. [4 ]
Woolley, A. G. [4 ]
Robinson, P. J. [2 ,3 ]
Braithwaite, A. W. [1 ,2 ,4 ]
机构
[1] Childrens Med Res Inst, Cell Transformat Unit, Westmead, NSW 2145, Australia
[2] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia
[3] Childrens Med Res Inst, Cell Signalling Unit, Westmead, NSW 2145, Australia
[4] Univ Otago, Dunedin Sch Med, Dept Pathol, Cell Transformat Grp, Dunedin, New Zealand
基金
英国医学研究理事会;
关键词
YB-1; oncoprotein; proteolysis; nuclear; translocation; BOX-BINDING-PROTEIN; MDR1; GENE-EXPRESSION; COLD SHOCK DOMAIN; P-GLYCOPROTEIN; DISEASE; CELLS; BINDING-PROTEIN-1; PROGRESSION; RESISTANCE; CISPLATIN;
D O I
10.1038/onc.2009.321
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Y-box-binding protein 1 (YB-1) is an oncogenic transcription factor whose overexpression and nuclear localization is associated with tumor progression and drug resistance. Transcriptional activation of YB-1 in response to genotoxic stress is believed to occur in the cytoplasm through sequence-specific endoproteolytic cleavage by the 20S Proteasome, followed by nuclear translocation of cleaved YB-1. To study the proteolysis model, we developed a two-step affinity purification of endogenous YB-1 protein species and characterized the products using mass spectrometry. Whereas full-length YB-1 was readily identified, the smaller protein band thought to be activated YB-1 was identified as hnRNP A1. An antibody specific for YB-1 was generated, which revealed only one YB-1 species, even after genotoxic stress-induced nuclear YB-1 translocation. These findings warrant re-evaluation of the mechanism of YB-1 nuclear translocation and transcriptional activation. The relationship between nuclear YB-1 and tumor progression may also have to re-evaluated in some cases. Oncogene (2010) 29, 403-410; doi:10.1038/onc.2009.321; published online 19 October 2009
引用
收藏
页码:403 / 410
页数:8
相关论文
共 20 条
[1]
INVOLVEMENT OF A DNA-BINDING PROTEIN, MDR-NF1/YB-1, IN HUMAN MDR1 GENE-EXPRESSION BY ACTINOMYCIN-D [J].
ASAKUNO, K ;
KOHNO, K ;
UCHIUMI, T ;
KUBO, T ;
SATO, S ;
ISONO, M ;
KUWANO, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 199 (03) :1428-1435
[2]
Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression [J].
Bargou, RC ;
Jurchott, K ;
Wagener, C ;
Bergmann, S ;
Metzner, S ;
Bommert, K ;
Mapara, MY ;
Winzer, KJ ;
Dietel, M ;
Dorken, B ;
Royer, HD .
NATURE MEDICINE, 1997, 3 (04) :447-450
[3]
Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells [J].
Berquin, IM ;
Pang, B ;
Dziubinski, ML ;
Scott, LM ;
Chen, YQ ;
Nolan, GP ;
Ethier, SP .
ONCOGENE, 2005, 24 (19) :3177-3186
[4]
The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma [J].
Chatterjee, Manik ;
Rancso, Christoph ;
Stuehmer, Thorsten ;
Eckstein, Niels ;
AndruliS, Mindaugas ;
Gerecke, Christian ;
Lorentz, Heike ;
Royer, Hans-Dieter ;
Bargoul, Ralf C. .
BLOOD, 2008, 111 (07) :3714-3722
[5]
Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel [J].
Fujita, T ;
Ito, KI ;
Izumi, H ;
Kimura, M ;
Sano, M ;
Nakagomi, H ;
Maeno, K ;
Hama, Y ;
Shingu, K ;
Tsuchiya, SI ;
Kohno, K ;
Fujimori, M .
CLINICAL CANCER RESEARCH, 2005, 11 (24) :8837-8844
[6]
YB-11s upregulated during prostate cancer tumor progression and increases P-glycoprotein activity [J].
Giménez-Bonafé, P ;
Fedoruk, MN ;
Whitmore, TG ;
Akbari, M ;
Ralph, JL ;
Ettinger, S ;
Gleave, ME ;
Nelson, CC .
PROSTATE, 2004, 59 (03) :337-349
[7]
The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signatures [J].
Guay, David ;
Evoy, Audrey-Ann ;
Paquet, Eric ;
Garand, Chantal ;
Bachvarova, Magdalena ;
Bachvarov, Dimcho ;
Lebel, Michel .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (11) :2492-2507
[8]
HORWITZ EM, 1994, J BIOL CHEM, V269, P14130
[9]
Y-box binding protein expression in thyroid neoplasms: Its linkage with anaplastic transformation [J].
Ito, Y ;
Yoshida, H ;
Shibahara, K ;
Uruno, T ;
Nakano, K ;
Takamura, Y ;
Miya, A ;
Kobayashi, K ;
Yokozawa, T ;
Matsuzuka, F ;
Uchimi, T ;
Kuwano, M ;
Miyoshi, E ;
Matsuura, N ;
Kuma, K ;
Miyauchi, A .
PATHOLOGY INTERNATIONAL, 2003, 53 (07) :429-433
[10]
The pleiotropic functions of the Y-box-binding protein, YB-1 [J].
Kohno, K ;
Izumi, H ;
Uchiumi, T ;
Ashizuka, M ;
Kuwano, M .
BIOESSAYS, 2003, 25 (07) :691-698